氨甲环酸在围手术期脊柱手术的应用进展
Application Progress of Tranexamic Acid in Perioperative Spinal Surgery
DOI: 10.12677/ACM.2023.1371688, PDF,   
作者: 黄治源：延安大学医学院，陕西 延安；刘志斌：延安大学附属医院脊柱外科，陕西 延安
关键词: 氨甲环酸；脊柱手术；研究进展；Tranexamic Acid； Spinal Surgery； Research Progress
摘要: 骨科脊柱大手术中常伴随大量失血的风险，如何减少患者围手术期出血、减少或避免输入异体血制品方法受许多骨科医生关注。近年来，氨甲环酸作为一种围手术期止血药及减少输血药物已得广泛关注，国内外许多学者报道氨甲环酸可以有效减少围手术期失血和输血，从而达到节约患者费用，改善患者预后。但其手术范围、最佳剂量、给药途径、不良反应等至今未能完全明确，需要进一步研究。
Abstract: The risk of massive blood loss in major orthopaedic spine surgery is often associated with how to reduce perioperative bleeding, and reduce or avoid the introduction of allogeneic blood products methods for many orthopedic surgeons. In recent years, tranexamic acid has been widely concerned as a perioperative hemostatic and blood transfusion drug. Many scholars at home and abroad have reported that tranexamic acid can effectively reduce perioperative blood loss and blood transfusion, so as to economize and improve the prognosis of the patients. However, the range of operation, op-timal dosage, route of administration and adverse reactions are not completely clear up to now and need further study.
文章引用：黄治源, 刘志斌. 氨甲环酸在围手术期脊柱手术的应用进展[J]. 临床医学进展, 2023, 13(7): 12045-12051. https://doi.org/10.12677/ACM.2023.1371688

参考文献

[1] Zollo, R.A., Eaton, M.P., Karcz, M., et al. (2012) Blood Transfusion in the Perioperative Period. Best Practice & Re-search Clinical Anaesthesiology, 26, 475-484. [Google Scholar] [CrossRef] [PubMed]
[2] 郭鸿飞, 张永刚, 姚子明, 等. 经椎弓根椎体截骨术治疗强直性脊柱炎后凸畸形术中大量出血的预测[J]. 中国骨与关节杂志, 2014, 3(10): 751-755.
[3] Fleege, C., Almajali, A., Rauschmann, M., et al. (2014) Improve of Surgical Outcomes in Spinal Fusion Surgery: Evidence Based Peri- and Intra-Operative Aspects to Reduce Complications and Earlier Recovery. Der Orthopade, 43, 1070-1078. [Google Scholar] [CrossRef] [PubMed]
[4] Ng, B.K., Chau, W.W., Hung, A.L., et al. (2015) Use of Tranexamic Acid (TXA) on Reducing Blood Loss during Scoliosis Surgery in Chinese Adolescents. Scoliosis, 10, Article No. 28. [Google Scholar] [CrossRef] [PubMed]
[5] Cheriyan, T., Maier, S.P., Bianco, K., et al. (2015) Efficacy of Tranexamic Acid on Surgical Bleeding in Spine Surgery: A Meta-Analysis. The Spine Journal, 15, 752-761. [Google Scholar] [CrossRef] [PubMed]
[6] Varney, S.J. and Guest, J.F. (2003) The Annual Cost of Blood Transfusions in the UK. Transfusion Medicine, 13, 205-218. [Google Scholar] [CrossRef] [PubMed]
[7] McCormack, P.L. (2012) Tranexamic Acid: A Review of Its Use in the Treatment of Excessive Fibrinolysis. Drugs, 72, 585-617. [Google Scholar] [CrossRef] [PubMed]
[8] 武昊天, 张欢. 围术期患者血液管理中氨甲环酸的应用进展[J]. 中国输血杂志, 2018, 31(12): 1421-1424. [Google Scholar] [CrossRef] 
[9] Ker, K., Edwards, P., Perel, P., et al. (2012) Ef-fect of Tranexamic Acid on Surgical Bleeding: Systematic Review and Cumulative Meta-Analysis. BMJ: British Medical Journal, 344, e3054. [Google Scholar] [CrossRef] [PubMed]
[10] 世界卫生组织世卫组织基本药物选择和使用专家委员会. 基本药物的选择和使用: 世卫组织专家委员会的报告, 2011年(包括第17份世卫组织基本药物标准清单和第三份世卫组织儿童基本药物标准清单) [Z]. 世界卫生组织, 2012.
[11] Dowd, N.P., Karski, J.M., Cheng, D.C., et al. (2002) Pharmacokinetics of Tranexamic Acid during Cardiopulmonary Bypass. Anesthesiology, 97, 390-399. [Google Scholar] [CrossRef] [PubMed]
[12] Hunt, B.J. (2015) The Current Place of Tranexamic Acid in the Management of Bleeding. Anaesthesia, 70, 50-53. [Google Scholar] [CrossRef] [PubMed]
[13] Lin, Z.X. and Woolf, S.K. (2016) Safety, Efficacy, and Cost-Effectiveness of Tranexamic Acid in Orthopedic Surgery. Orthopedics, 39, 119-130. [Google Scholar] [CrossRef] [PubMed]
[14] Ehresman, J., Pennington, Z., Schilling, A., et al. (2020) Cost-Benefit Analysis of Tranexamic Acid and Blood Transfusion in Elective Lumbar Spine Surgery for Degenerative Pathologies. Journal of Neurosurgery: Spine SPI, 33, 177-185. [Google Scholar] [CrossRef] 
[15] Li, Z.J., et al. (2013). Is Tranexamic Acid Effective and Safe in Spinal Surgery? A Meta-Analysis of Randomized Controlled Trials. European Spine Journal, 22, 1950-1957.[CrossRef] [PubMed]
[16] Halanski, M.A., Cassidy, J.A., Hetzel, S., et al. (2014) The Effi-cacy of Amicar versus Tranexamic Acid in Pediatric Spinal Deformity Surgery: A Prospective, Randomized, Dou-ble-Blinded Pilot Study. Spine Deformity, 2, 191-197. [Google Scholar] [CrossRef] [PubMed]
[17] Hasan, M.S., et al. (2021) Tranexamic Acid in Pediatric Scoliosis Surgery: A Prospective Randomized Trial Comparing High-Dose and Low-Dose Tranexamic Acid in Adolescent Idio-pathic Scoliosis Undergoing Posterior Spinal Fusion Surgery. Spine, 46, E1170-E1177. [Google Scholar] [CrossRef] 
[18] Garg, B., Dhatt, S. and Chakraborty, S. (2012) Use of Sin-gle-Dose Tranexamic Acid to Reduce Blood Loss in Operative Thoracolumbar Trauma: A Comparative Study. The Spine Journal, 12, S93. [Google Scholar] [CrossRef] 
[19] Raksakietisak, M., Sathitkarnmanee, B., Srisaen, P., et al. (2015) Two Doses of Tranexamic Acid Reduce Blood Transfusion in Complex Spine Surgery: A Prospective Randomized Study. Spine (Phila Pa 1976), 40, E1257-E1263. [Google Scholar] [CrossRef] 
[20] Endres, S., Heinz, M. and Wilke, A. (2011) Efficacy of Tranexamic Acid in Reducing Blood Loss in Posterior Lumbar Spine Surgery for Degenerative Spinal Stenosis with In-stability: A Retrospective Case Control Study. BMC Surgery, 11, Article No. 29. [Google Scholar] [CrossRef] [PubMed]
[21] Baldus, C.R., Bridwell, K.H., Lenke, L.G., et al. (2010) Can We Safely Reduce Blood Loss during Lumbar Pedicle Subtraction Osteotomy Procedures Using Tranexamic Acid or Apro-tinin? A Comparative Study with Controls. Spine (Phila Pa 1976), 35, 235-239. [Google Scholar] [CrossRef] 
[22] Colomina, M.J., Koo, M., Basora, M., et al. (2017) In-traoperative Tranexamic Acid Use in Major Spine Surgery in Adults: A Multicentre, Randomized, Placebo-Controlled Trial. British Journal of Anaesthesia, 118, 380-390. [Google Scholar] [CrossRef] [PubMed]
[23] Grant, J.A., Howard, J., Luntley, J., et al. (2009) Perioperative Blood Transfusion Requirements in Pediatric Scoliosis Surgery: The Efficacy of Tranexamic Acid. Journal of Pediatric Ortho-paedics, 29, 300-304. [Google Scholar] [CrossRef] 
[24] Verma, K., Kohan, E., Ames, C.P., et al. (2015) A Compar-ison of Two Different Dosing Protocols for Tranexamic Acid in Posterior Spinal Fusion for Spinal Deformity: A Pro-spective, Randomized Trial. International Journal of Spine Surgery, 9, 65. [Google Scholar] [CrossRef] [PubMed]
[25] Yee, B.E., Wissler, R.N., Zanghi, C.N., et al. (2013) The Effective Concentration of Tranexamic Acid for Inhibition of Fibri-nolysis in Neonatal Plasma in Vitro. Anesthesia & Analgesia, 117, 767-772. [Google Scholar] [CrossRef] 
[26] Irwin, A., Khan, S.K., Jameson, S.S., et al. (2013) Oral versus Intravenous Tranexamic Acid in Enhanced-Recovery Primary Total Hip and Knee Replacement. The Bone & Joint Journal, 95-B, 1556-1561. [Google Scholar] [CrossRef] 
[27] Winter, S.F., Santaguida, C., Wong, J., et al. (2015) Sys-temic and Topical Use of Tranexamic Acid in Spinal Surgery: A Systematic Review. Global Spine Journal, 6, 284-295. [Google Scholar] [CrossRef] [PubMed]
[28] Hui, S., Peng, Y., Tao, L., et al. (2021) Tranexamic Acid Given into Wound Reduces Postoperative Drainage, Blood Loss, and Hospital Stay in Spinal Surgeries: A Meta-Analysis. Journal of Orthopaedic Surgery and Research, 16, Article No. 401. [Google Scholar] [CrossRef] [PubMed]
[29] Andersson, L., Nilsoon, I.M., Colleen, S., et al. (1968) Man-agement of Urokinase and Tissue Activators in the Maintenance of Bleeding by EACA and AMCA. Annals of the New York Academy of Sciences, 146, 642-656. [Google Scholar] [CrossRef] [PubMed]
[30] Cao, Z., Li, Q., Guo, J., et al. (2022) Optimal Admin-istration Strategies of Tranexamic Acid to Minimize Blood Loss during Spinal Surgery: Results of a Bayesian Network Meta-Analysis. Annals of Medicine, 54, 2053-2063. [Google Scholar] [CrossRef] [PubMed]
[31] Benoni, G., Lethagen, S. and Fredin, H. (1997) The Effect of Tranexamic Acid on Local and Plasma Fibrinolysis during Total Knee Arthroplasty. Thrombosis Research, 85, 195-206. [Google Scholar] [CrossRef] 
[32] Goodnough, L.T., Shander, A. and Brecher, M.E. (2003) Transfusion Medicine: Looking to the Future. The Lancet, 361, 161-169. [Google Scholar] [CrossRef] 
[33] Brown, J.R., Birkmeyer, N.J. and O’Connor, G.T. (2007) Meta-Analysis Comparing the Effectiveness and Adverse Outcomes of Antifibrinolytic Agents in Cardiac Surgery. Cir-culation, 115, 2801-2813. [Google Scholar] [CrossRef] 
[34] Lake, I., Wang, D.S., Whitssel, P.D., et al. (2016) Etiology and Treatment of Tranexamic Acid-Related Seizures. Journal of Neurology, 79, 18-26. [Google Scholar] [CrossRef] [PubMed]
[35] Lin, Z. and Xiao, Y. (2016) Meta-Analysis of Tranexamic Acid-Associated Seizures. Seizure, 36, 70-73. [Google Scholar] [CrossRef] [PubMed]
[36] Cravens, G.T., Brown, M.J., Brown, D.R., et al. (2006) Anti-fibrinolytic Therapy Use to Mitigate Blood Loss during Staged Complex Major Spine Surgery: Postoperative Visual Color Changes after Tranexamic Acid Administration. Anesthesiology, 105, 1274-1276.

为你推荐